29Aug/13

Novel Approach to Amyloidosis Looks Promising – MedPage Today

Novel Approach to Amyloidosis Looks Promising
MedPage Today
“The ability of [the second-generation drug] to lower both mutant and nonmutant proteins may also provide a major advantage over liver transplantation, which affects the production of only mutant protein.” Though it was a phase I, proof-of-principle
Alnylam and Collaborators Publish Clinical Trial Results with RNAi DailyFinance

all 4 news articles »

29Aug/13

Now Available: Liver Transplantation – Pipeline Review, H2 2013 – SBWire (press release)

Now Available: Liver Transplantation – Pipeline Review, H2 2013
SBWire (press release)
Boston, MA — (SBWIRE) — 08/29/2013 — Global Markets Direct’s, ‘Liver Transplantation – Pipeline Review, H2 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for

and more »